Page last updated: 2024-10-24

carmustine and MODS

carmustine has been researched along with MODS in 1 studies

Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Papadakis, V1
Dunkel, IJ1
Cramer, LD1
Kramer, E1
Papadopoulos, E1
Goldman, S1
Packer, RJ1
Willoughby, M1
Baker, D1
Garvin, J1
Strandjord, S1
Coccia, P1
Kaplan, AM1
Klemperer, M1
Finlay, JL1

Other Studies

1 other study available for carmustine and MODS

ArticleYear
High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors.
    Bone marrow transplantation, 2000, Volume: 26, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carm

2000